Shigehiro Shimosaka

Statistics

Publications

Citations

H-Index

Active since

2007

Affiliations

Kohno Clinical Medicine Research Institute(Current)

Shigehiro Shimosaka is an author at Kohno Clinical Medicine Research Institute specializing in anti-inflammatory pharmacology, proinflammatory cytokine modulation, and inflammation.

Publications per year

2007–2007

Publications

(+)-Syringaresinol-di-O-β-d-glucoside, a phenolic compound from Acanthopanax senticosus Harms, suppresses proinflammatory mediators in SW982 human synovial sarcoma cells by inhibiting activating protein-1 and/or nuclear factor-κB activities

Taisuke Yamazaki, Shigehiro Shimosaka, Hideyuki Sasaki et al. · Toxicology in Vitro · 2007 · 71 citations

Medicine, Oncology, Pharmacology +13

1–1 of 1